What is the recommended dosing of Augmentin (amoxicillin-clavulanate) for preseptal cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Augmentin Dosing for Preseptal Cellulitis

For adults with preseptal cellulitis, high-dose amoxicillin-clavulanate at 4 g of amoxicillin with 250 mg of clavulanate per day divided into two doses is the recommended treatment. 1

Adult Dosing Recommendations

  • High-dose amoxicillin-clavulanate (4 g amoxicillin/250 mg clavulanate per day divided into two doses) is the preferred regimen for preseptal cellulitis in adults 1
  • Treatment duration should be 5-10 days, individualized based on clinical response 2, 1
  • The shorter 5-6 day course is supported by recent evidence for nonpurulent cellulitis when patients can self-monitor and have close follow-up 2

Pediatric Dosing Recommendations

  • For children with preseptal cellulitis, high-dose amoxicillin-clavulanate at 90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanate divided into two doses is recommended 1
  • The pediatric formulation provides a 14:1 ratio of amoxicillin to clavulanate in an oral suspension 1
  • Treatment duration for children is typically 10-14 days 1

Rationale for Amoxicillin-Clavulanate Selection

  • Amoxicillin-clavulanate is preferred over amoxicillin alone due to better coverage against β-lactamase-producing organisms, including Streptococcus species and Staphylococcus aureus 1
  • High-dose formulation overcomes potential resistance in Streptococcus pneumoniae with high MICs 1
  • For nonpurulent cellulitis like preseptal cellulitis, empirical therapy for β-hemolytic streptococci is recommended, with consideration for MRSA coverage in patients who don't respond to β-lactam therapy 2

Treatment Considerations

  • For mild cases of preseptal cellulitis, outpatient treatment with high-dose amoxicillin-clavulanate is appropriate with daily follow-up 1
  • If no improvement occurs within 24-48 hours or if infection is progressive, hospitalization for intravenous antibiotics is warranted 1
  • For patients with proptosis, impaired visual acuity, or impaired/painful extraocular mobility, immediate hospitalization and intravenous antibiotics are necessary 1
  • Daily follow-up is recommended until definite improvement is noted for outpatient treatment 1

Alternative Regimens

  • If no improvement occurs within 72 hours, consider switching to alternative antibiotics, such as clindamycin plus cefixime, linezolid plus cefixime, or levofloxacin 1
  • For patients with MRSA concerns, options include clindamycin (300-450 mg PO TID for adults), trimethoprim-sulfamethoxazole, doxycycline, or linezolid 2
  • Avoid first-generation cephalosporins like cephalexin as they may be ineffective for this condition 1

Potential Complications and Monitoring

  • Complications of preseptal cellulitis can include progression to orbital cellulitis, which may lead to permanent blindness if not treated promptly 1, 3
  • Laboratory findings such as elevated white blood cell count, erythrocyte sedimentation rate, and C-reactive protein levels may be significantly higher in orbital cellulitis compared to preseptal cellulitis 4
  • Clinical experience has shown that sulbactam-ampicillin (a similar β-lactam/β-lactamase inhibitor combination) has been effective in treating preseptal and orbital cellulitis 4

References

Guideline

Amoxicillin-Clavulanate Dosage for Preseptal Cellulitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Orbital cellulitis in children].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.